The following are a selection of scientific meetings and conferences on or related to cancer research. If you would like to include a conference on this list, please email email@example.com with the details and the link to the conference website.
Date: 31 May - 4 June 2013
Location: Chicago, Illinois, USA
This meeting brings together thousands of oncology professionals from a broad range of specialties to discuss topics under the theme - Building Bridges to Conquer Cancer.
Date: 12 - 14 June 2013
Location: Brighton, UK
This conference will highlight how national cancer intelligence is improving the understanding and delivery of awareness; diagnosis; treatment; outcomes and the cost of cancer in the UK.
Date: 19 - 28 June 2013
Location: Hinxton, Cambridge, UK
This laboratory and computer-based training course introduces participants to a wide range of post-genome techniques including practical experience in performing RNAi experiments, expression profiling using the latest platforms, yeast 2-hybrid analyses and hands on experience with sample preparation procedures for Illumina high throughput sequencing.
Date: 22 - 28 June 2013
The aim of this workshop is to develop a strong, expanding base of well-trained clinical researchers by providing them with the training they need to develop and conduct better clinical/translational trial designs.
Date: 3 - 4 July 2013
Location: University of Bristol
This meeting aims to highlight the latest advances in tumour growth and metastasis. Knowledge of the role of the tumour microenvironment has been developing rapidly, and therapies aimed at tumour vasculature and lymphatics, immune interactions, and stromal components are now increasingly available. Therefore this meeting aims to highlight the latest advances in this field from basic science to clinical development.
Date: 7 - 10 July 2013
Location: Glasgow, Scotland
This meeting will highlight recent exciting research into the role played by the tumour stroma in cancer progression and how agents may be developed to treat the disease by targeting tumour associated cells, such as immune cells and fibroblasts, the tumour vasculature and the tumour extracellular matrix.
Date: 15 - 17 September 2013
Location: Hinxton, Cambridge, UK
The development of new cancer therapies is increasingly guided by our understanding of the molecular basis of cancer. As worldwide efforts are beginning to provide a comprehensive description of the genomic, transcriptomic and epigenomic changes that occur in cancer, the field of cancer pharmacogenomics will be at the forefront of a new generation of rationally designed cancer therapies incorporating molecular biomarkers. This conference is aimed at scientists and clinician-scientists in academia or industry and will seek to address many of the key challenges in the design, development and clinical implementation of targeted cancer therapies.
Date: 6 - 8 October 2013
Location: Sitges, Spain
This meeting aims to gather experts in the field of cancer, genomics, chromatin biology, systems biology and chemical biology to discuss the rapidly advancing field of cancer epigenomics and its imminent impact on new cancer therapies.
Date: 27 - 30 October 2013
Location: Madrid, Spain
Tumour heterogeneity and plasticity have substantial implications for fundamental and clinical cancer research. Experts will discuss the clonal evolution of cancer; the microenvironment and heterogeneity; tumour cell plasticity and tumour heterogeneity in the clinic.
Date: 3 - 6 November 2013
Location: Liverpool, UK
This, the ninth NCRI Cancer Conference, is a major cancer research meeting that takes place in the UK. Choose from over 50 sessions and 150 speakers presenting high-quality data in a multidisciplinary programme - from basic research to prevention, diagnosis, treatment and survivorship.
Date: 18 - 19 November 2013
Location: Edinburgh, Scotland
The conference will provide a perfect forum for the exchange of new ideas amongst all individuals with an interest in clinical trials. Topics will include the identification of interventions to be taken forward into a clinical trial, and the design, conduct, oversight, analysis, interpretation and reporting of the trial.